Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, announced that it will share real-world data about ...

We are positioned for significant expansion in 2025 with the FDA decision on approval of our pre-filled syringe, global CIDP rollout, and label-expansion studies ... and in the role of MuSK at the ...

Liver issues, including a buildup of fat in the liver, occur before the onset of neuromuscular disease, per a study in a mouse model of SMA.

Neuromuscular disease refers to a group of heterogeneous disorders that impair the function of motor nerves, muscles or neuromuscular junctions. Symptoms can include muscle pain, weakness or ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

To help combat the nation’s chronic disease crisis, the FDA has announced a proposal for a rule that would require front-of-package labeling for nutritional information. If finalized ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins Some states have laws and ethical rules regarding solicitation and ...

We are positioned for significant expansion in 2025 with the FDA decision on approval of our pre-filled syringe, global CIDP rollout, and label-expansion studies underway for MG. To further ...

We are positioned for significant expansion in 2025 with the FDA decision on approval of our pre-filled syringe, global CIDP rollout, and label-expansion studies underway for MG. To further support ...

The terrorist label could also push big parts of Mexico’s economy further into the shadows, where cash is used instead of electronically traceable transactions, making it harder for ...